Clinical relevance of FLT3 gene abnormalities in Brazilian patients with infant leukemia

Leukemia and Lymphoma

Volumn 49, Issue 12, 2008, Pages 2291-2297

  Emerenciano, Mariana ^a   Menezes, Juliane ^a   Vasquez, Marina Lipkin ^a   Zalcberg, Ilana ^a   Thuler, Luiz Claudio Santos ^b   Pombo de Oliveira, Maria ^a  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

Author keywords

Acute lymphoblastic leukemia; Acute myeloid leukemia; FLT3; Hyperdiploid; Infant acute leukemia; MLL

Indexed keywords

CD135 ANTIGEN; MIXED LINEAGE LEUKEMIA PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BRAZIL; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC DISORDER; HUMAN; HUMAN CELL; INFANT; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SURVIVAL TIME; WILD TYPE;

BRAZIL; DNA MUTATIONAL ANALYSIS; FMS-LIKE TYROSINE KINASE 3; HUMANS; INFANT; INFANT, NEWBORN; INVERTED REPEAT SEQUENCES; LEUKEMIA; LEUKOCYTE COUNT; MUTATION, MISSENSE; MYELOID-LYMPHOID LEUKEMIA PROTEIN; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 57449114696     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190802491698     Document Type: Article

References (32)

1. Biondi, A., Cimino, G., Pieters, R. and Pui, C. H. (2000) Biological and therapeutic aspects of infant leukemia. Blood, 96, pp. 24-33.
2. Pui, C. H., Chessells, J. M., Camitta, B., Baruchel, A., Biondi, A. Boyett, J. M. et al. (2003) Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements. Leukemia, 17, pp. 700-706.
3. Cimino, G., Rapanotti, M. C., Rivolta, A., Lo, C. F., D'Arcangelo, E. Rondelli, R. et al. (1995) Prognostic relevance of ALL-1 gene rearrangement in infant acute leukemias. Leukemia, 9, pp. 391-395.
4. Pui, C. H., Gaynon, P. S., Boyett, J. M., Chessells, J. M., Baruchel, A. Kamps, W. et al. (2002) Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet, 359, pp. 1909-1915.
5. Biondi, A., Rizzari, C., Valsecchi, M. G., De, L. P., Arico, M. Basso, G. et al. (2006) Role of treatment intensification in infants with acute lymphoblastic leukemia: Results of two consecutive AIEOP studies. Haematologica, 91, pp. 534-537.
6. Chessells, J. M., Harrison, C. J., Watson, S. L., Vora, A. J. and Richards, S. M. (2002) Treatment of infants with lymphoblastic leukaemia: Results of the UK Infant Protocols 1987-1999. Br J Haematol, 117, pp. 306-314.
7. Pieters, R., Schrappe, M., De, L. P., Hann, I., De, R. G. Felice, M. et al. (2007) A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): An observational study and a multicentre randomised trial. Lancet, 370, pp. 240-250.
8. Pui, C. H., Ribeiro, R. C., Campana, D., Raimondi, S. C., Hancock, M. L. Behm, F. G. et al. (1996) Prognostic factors in the acute lymphoid and myeloid leukemias of infants. Leukemia, 10, pp. 952-956.
9. Satake, N., Maseki, N., Nishiyama, M., Kobayashi, H., Sakurai, M. Inaba, H. et al. (1999) Chromosome abnormalities and MLL rearrangements in acute myeloid leukemia of infants. Leukemia, 13, pp. 1013-1017.
10. Armstrong, S. A., Staunton, J. E., Silverman, L. B., Pieters, R., den Boer, M L Minden, M. D. et al. (2002) MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet, 30, pp. 41-47.
11. Fine, B. M., Stanulla, M., Schrappe, M., Ho, M., Viehmann, S. Harbott, J. et al. (2004) Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia. Blood, 103, pp. 1043-1049.
12. Gilliland, D. G. and Griffin, J. D. (2002) The roles of FLT3 in hematopoiesis and leukemia. Blood, 100, pp. 1532-1542.
13. Nakao, M., Yokota, S., Iwai, T., Kaneko, H., Horiike, S. Kashima, K. et al. (1996) Internal tandem duplication of the FLT3 gene found in acute myeloid leukemia. Leukemia, 10, pp. 1911-1918.
14. Kiyoi, H., Towatari, M., Yokota, S., Hamaguchi, M., Ohno, R. Saito, H. et al. (1998) Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product. Leukemia, 12, pp. 1333-1337.
15. Scheijen, B. and Griffin, J. D. (2002) Tyrosine kinase oncogenes in normal hematopoiesis and hematological disease. Oncogene, 21, pp. 3314-3333.
16. Abu-Duhier, F. M., Goodeve, A. C., Wilson, G. A., Care, R. S., Peake, I. R. and Reilly, J. T. (2001) Identification of novel FLT-3 Asp835 mutations in adult acute myeloid leukaemia. Br J Haematol, 113, pp. 983-988.
17. Meshinchi, S., Alonzo, T. A., Stirewalt, D. L., Zwaan, M., Zimmerman, M. Reinhardt, D. et al. (2006) Clinical implications of FLT3 mutations in pediatric AML. Blood, 108, pp. 3654-3661.
18. Thiede, C., Steudel, C., Mohr, B., Schaich, M., Schakel, U. Platzbecker, U. et al. (2002) Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: Association with FAB subtypes and identification of subgroups with poor prognosis. Blood, 99, pp. 4326-4335.
19. Xu, F., Taki, T., Yang, H. W., Hanada, R., Hongo, T. Ohnishi, H. et al. (1999) Tandem duplication of the FLT3 gene is found in acute lymphoblastic leukaemia as well as acute myeloid leukaemia but not in myelodysplastic syndrome or juvenile chronic myelogenous leukaemia in children. Br J Haematol, 105, pp. 155-162.
20. Yamamoto, Y., Kiyoi, H., Nakano, Y., Suzuki, R., Kodera, Y. Miyawaki, S. et al. (2001) Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies. Blood, 97, pp. 2434-2439.
21. Xu, F., Taki, T., Eguchi, M., Kamada, N., Ishii, E. Endo, M. et al. (2000) Tandem duplication of the FLT3 gene is infrequent in infant acute leukemia. Japan Infant Leukemia Study Group. Leukemia, 14, pp. 945-947.
22. Armstrong, S. A., Kung, A. L., Mabon, M. E., Silverman, L. B., Stam, R. W. den Boer, M L et al. (2003) Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification. Cancer Cell, 3, pp. 173-183.
23. Armstrong, S. A., Mabon, M. E., Silverman, L. B., Li, A., Gribben, J. G. Fox, E. A. et al. (2004) FLT3 mutations in childhood acute lymphoblastic leukemia. Blood, 103, pp. 3544-3546.
24. Taketani, T., Taki, T., Sugita, K., Furuichi, Y., Ishii, E. Hanada, R. et al. (2004) FLT3 mutations in the activation loop of tyrosine kinase domain are frequently found in infant ALL with MLL rearrangements and pediatric ALL with hyperdiploidy. Blood, 103, pp. 1085-1088.
25. Stam, R. W., den Boer, M L, Schneider, P., Meier, M., Beverloo, H. B. and Pieters, R. (2007) D-HPLC analysis of the entire FLT3 gene in MLL rearranged and hyperdiploid acute lymphoblastic leukemia. Haematologica, 92, pp. 1565-1568.
26. Pombo-de-Oliveira, M. S. and Koifman, S. (2006) Infant acute leukemia and maternal exposures during pregnancy. Cancer Epidemiol Biomarkers Prev, 15, pp. 2336-2341.
27. Emerenciano, M., Agudelo Arias, D P, Coser, V. M., Brito, G. D., Macedo Silva, M L and Pombo-de-Oliveira, M. S. (2006) Molecular cytogenetic findings of acute leukemia included in the Brazilian Collaborative Study Group of Infant acute leukemia. Pediatr Blood Cancer, 47, pp. 549-554.
28. Miller, S. A., Dykes, D. D. and Polesky, H. F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res, 16, p. 1215.
29. Schnittger, S., Schoch, C., Dugas, M., Kern, W., Staib, P. Wuchter, C. et al. (2002) Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: Correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease. Blood, 100, pp. 59-66.
30. Stam, R. W., den Boer, M L, Schneider, P., Nollau, P., Horstmann, M. Beverloo, H. B. et al. (2005) Targeting FLT3 in primary MLL-gene-rearranged infant acute lymphoblastic leukemia. Blood, 106, pp. 2484-2490.
31. Howard, S. C., Pedrosa, M., Lins, M., Pedrosa, A., Pui, C. H. Ribeiro, R. C. et al. (2004) Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area. JAMA, 26, pp. 2471-2475.
32. Ribeiro, K. B., Lopes, L. F. and de Camargo, B. (2007) Trends in childhood leukemia mortality in Brazil and correlation with social inequalities. Cancer, 110, pp. 1823-1831.